Physician profile
Wanda Hu
NPI 1972803666
$10,729.35
in general payments reported to CMS, 2019-2025
14 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,631 · 2020: $79.90 · 2022: $128 · 2023: $329 · 2024: $368 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597 · Long Term Medical Supply Or Device Loan: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.24 |
| Long Term Medical Supply Or Device Loan | $293.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $8,558.95 | 2019 | |
| Allergan, INC. | $763.39 | 2019-2022 | |
| Amgen INC. | $438.74 | 2024-2025 | Pavblu |
| Carl Zeiss Meditec USA, INC. | $293.83 | 2023 | Cirrus 5000 With Angioplex |
| Johnson & Johnson Surgical Vision, INC. | $148.11 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $142.43 | 2019 | |
| Sun Pharmaceutical Industries INC. | $109.10 | 2019 | |
| Sight Sciences, INC. | $88.30 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $64.89 | 2019-2025 | Hydrus Microstent |
| Akorn, INC. | $34.44 | 2019 | |
| Novartis Pharmaceuticals Corporation | $33.97 | 2019 | |
| Shire North American Group INC | $23.02 | 2019 | |
| Glaukos Corporation | $16.33 | 2019 | |
| Thea Pharma INC. | $13.85 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanda Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.